| Staci Tagawa, | |
|
17284 Slover Ave Ste 204, Fontana, CA 92337-7584 | |
| (909) 609-3329 | |
| Not Available |
| Full Name | Staci Tagawa |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 17284 Slover Ave Ste 204, Fontana, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821469529 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 72987 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Staci Tagawa, 17284 Slover Ave Ste 204, Fontana, CA 92337-7584 Ph: () - | Staci Tagawa, 17284 Slover Ave Ste 204, Fontana, CA 92337-7584 Ph: (909) 609-3329 |
News Archive
Aprotinin, a drug used for limiting blood loss in patients undergoing cardiac surgery, is associated with an increased risk of death during five years following the surgery, according to a new study in the February 7 issue of JAMA: The Journal of the American Medical Association.
In a new study, University of Maryland School of Medicine researchers have had promising results with a new treatment for Middle East Respiratory Syndrome (MERS). The study, published today in the journal Science Translational Medicine, found a new treatment that protected mice from MERS infection.
Ahead of World Malaria Day (25 April), EU-funded researchers have discovered that drugs originally designed to inhibit the growth of cancer cells can also kill the parasite that causes malaria. They believe this discovery could open up a new strategy for combating this deadly disease, which, according to World Health Organisation statistics, infected around 225 million and killed nearly 800 000 people worldwide in 2009.
Viron Therapeutics Inc. announced that VT-346, an anti-TNF protein therapeutic, demonstrated positive results in a pivotal proof of concept study in the gold standard transgenic mouse model for arthritis. VT-346 achieved a statistically significant, dose dependent impact in this preclinical model of arthritis and prevented deterioration due to disease in terms of weight gain, arthritic score and pathology parameters. VT-346 had particularly strong protective effects on therapeutically-important bone and cartilage damage in this model.
› Verified 3 days ago
Gilda F Tan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16910 Foothill Blvd, Fontana, CA 92335 Phone: 909-350-0493 Fax: 909-350-2025 | |
Mona Abdou, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16225 Sierra Lakes Pkwy, Fontana, CA 92336 Phone: 909-357-2525 | |
Mr. Dhiresh N Patel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-302-8018 | |
Usama Labib, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9985 Sierra Ave Fl Link2, Fontana, CA 92335 Phone: 909-427-4914 | |
Dr. Carla Espinoza, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16964 Slover Ave, Fontana, CA 92337 Phone: 909-356-0540 | |
Karen Bae, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17284 Slover Ave Ste 204, Fontana, CA 92337 Phone: 909-609-3313 | |
Sani Hanh Pham, PHARM, D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-427-5335 |